Adjunctive Intranasal Esketamine in Treatment-Resistant Depression

JAMA Psychiatry. 2018 Jun 1;75(6):654. doi: 10.1001/jamapsychiatry.2018.0690.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Administration, Intranasal
  • Antidepressive Agents
  • Depression
  • Depressive Disorder, Treatment-Resistant*
  • Humans
  • Ketamine*

Substances

  • Antidepressive Agents
  • Ketamine